Subscribe to RSS

DOI: 10.1055/a-2344-8244
Clofazimine enteropathy: a case of pigmentation of the whole small intestine caused by clofazimine
Authors

Clofazimine is mainly used for the treatment of neoplastic leprosy, and can also be used in combination with other anti-tuberculosis drugs to treat multidrug-resistant tuberculosis.
As is well known, clofazimine can within weeks cause skin pigmentation in 75% to 100% of patients, or, uncommonly, ichthyosis [11]. One of the most serious gastrointestinal side effects of clofazimine is deposition of black-purple crystals in the small bowel lamina propria, which leads to hyperpigmentation in the intestines. This most serious side effect of clofazimine, although rare, can result in severe or even fatal enteropathy [22]. We report a case of intestinal injury caused by clofazimine. After timely diagnosis and cessation of medication, the patient’s condition has significantly improved.
Our 32-year-old patient with drug-resistant tuberculosis developed abdominal pain after receiving anti-tuberculosis treatment with pyrazinamide, clofazimine, levofloxacin, and iminicotinamide for 16 months. Physical examination revealed that the skin on his back was reddish brown ([Fig. 1Fig. 1]), and the anterior tibial skin of both his lower limbs showed fish-scale-like changes ([Fig. 2Fig. 2]). Colonoscopy showed melanosis in the terminal ileum. The pathological report stated that tissue cells could be seen in the lesion area, and crystal-like substances could be seen inside ([Fig. 3Fig. 3]). Capsule endoscopy showed continuous pigmentation of the jejunum and ileum, with pigmentation of the jejunum being prominent ([Video 1Video 1]).






Clofazimine treatment was stopped, and within 5 months the patient’s abdominal pain disappeared and the pigmentation and fish-scale-like changes in the back and lower limbs decreased.
Endoscopy_UCTN_Code_CCL_1AB_2AH_3AB
E-Videos is an open access online section of the journal Endoscopy, reporting on interesting cases and new techniques in gastroenterological endoscopy.
All papers include a high-quality video and are published with a Creative Commons
CC-BY license. Endoscopy E-Videos qualify for HINARI discounts and waivers and eligibility is automatically checked during the submission
process. We grant 100% waivers to articles whose corresponding authors are based in
Group A countries and 50% waivers to those who are based in Group B countries as classified
by Research4Life (see: https://www.research4life.org/access/eligibility/).
This section has its own submission website at https://mc.manuscriptcentral.com/e-videos.
Publication History
Article published online:
03 July 2024
© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/).
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Lawrence J, Brandt MD. An unusual cause of small-intestine mucosal pigmentation. Gastrointest Endosc 2011; 73: 1285-1286
- 2 Arbiser JL, Moschella SL. Clofazimine: a review of its medical uses and mechanisms of action. J Am Acad Dermatol 1995; 32: 241-247